beta
/IMpower150 Study Group, Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Data not found

Cited By (0)